Mallinckrodt PLC (MCKPF)
0.12
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Mallinckrodt Enterprise Value: 1.458B for Sept. 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
September 18, 2024 | 1.458B |
September 17, 2024 | 1.458B |
September 16, 2024 | 1.458B |
September 13, 2024 | 1.458B |
September 12, 2024 | 1.458B |
September 11, 2024 | 1.458B |
September 10, 2024 | 1.458B |
September 09, 2024 | 1.458B |
September 06, 2024 | 1.458B |
September 05, 2024 | 1.458B |
September 04, 2024 | 1.458B |
September 03, 2024 | 1.458B |
August 30, 2024 | 1.458B |
August 29, 2024 | 1.458B |
August 28, 2024 | 1.458B |
August 27, 2024 | 1.458B |
August 26, 2024 | 1.458B |
August 23, 2024 | 1.458B |
August 22, 2024 | 1.458B |
August 21, 2024 | 1.458B |
August 20, 2024 | 1.458B |
August 19, 2024 | 1.458B |
August 16, 2024 | 1.458B |
August 15, 2024 | 1.458B |
August 14, 2024 | 1.458B |
Date | Value |
---|---|
August 13, 2024 | 1.458B |
August 12, 2024 | 1.458B |
August 09, 2024 | 1.458B |
August 08, 2024 | 1.458B |
August 07, 2024 | 1.458B |
August 06, 2024 | 1.458B |
August 05, 2024 | 1.458B |
August 02, 2024 | 1.458B |
August 01, 2024 | 1.458B |
July 31, 2024 | 1.458B |
July 30, 2024 | 1.458B |
July 29, 2024 | 1.458B |
July 26, 2024 | 1.458B |
July 25, 2024 | 1.458B |
July 24, 2024 | 1.458B |
July 23, 2024 | 1.458B |
July 22, 2024 | 1.458B |
July 19, 2024 | 1.458B |
July 18, 2024 | 1.458B |
July 17, 2024 | 1.458B |
July 16, 2024 | 1.458B |
July 15, 2024 | 1.458B |
July 12, 2024 | 1.458B |
July 11, 2024 | 1.458B |
July 10, 2024 | 1.458B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.458B
Minimum
Jun 30 2024
1.503B
Maximum
Mar 31 2024
1.488B
Average
1.502B
Median
Jan 16 2024
Enterprise Value Benchmarks
Alkermes PLC | 3.998B |
Jazz Pharmaceuticals PLC | 10.49B |
Medtronic PLC | 133.22B |
Perrigo Co PLC | 7.361B |
Iterum Therapeutics PLC | 19.92M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -43.30M |
Revenue (Quarterly) | 514.30M |
Total Expenses (Quarterly) | 476.40M |
EPS Diluted (Quarterly) | -2.20 |
Gross Profit Margin (Quarterly) | 37.92% |
Profit Margin (Quarterly) | -8.42% |
Earnings Yield | -159.0K% |
Normalized Earnings Yield | -79219.34 |